Cameron Elizabeth Comrie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cameron Elizabeth Comrie has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Chad B. Sussman
Harvard Medical School, Boston, Massachusetts
21 shared publications - Daniel George Packard
Department of Internal Medicine Mayo Clinic Rochester Minnesota USA
21 shared publications - James W. Webber
Brigham and Women's Hospital
21 shared publications - Kevin Meyer Elias
Dana-Farber Cancer Institute 1 Department of Medical Oncology Boston, Massachusetts
21 shared publications - Laura Wollborn
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Boston, Massachusetts
21 shared publications - Marta Williams
Harvard Medical School, Boston, Massachusetts
21 shared publications
Latest Publications
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Data from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Background:Serum miRNAs are potential biomarkers for ovarian cancer; however, many factors may influence miRNA expression. To understand potential confounders in miRNA analysis, we examined how sociodemographic factors and comorbidities, including known ovarian cancer risk factors, influence serum miRNA levels in women without ovarian cancer.Methods:Data from 1,576 women from the Mass General Brigham Biobank collected between 2012 and 2019, excluding subjects previously or subsequently diagnosed with ovarian cancer, were examined. Using a focused panel of 179 miRNA probes optimized for serum profiling, miRNA expression was measured by flow cytometry using the Abcam FirePlex assay and correlated with subjects’ electronic medical records.Results:The study population broadly reflected the New England population. The median age of subjects was 49 years, 34% were current or prior smokers, 33% were obese (body mass index > 30 kg/m2), 49% were postmenopausal, and 11% had undergone prior bilateral oophorectomy. Significant differences in miRNA expression were observed among ovarian risk factors such as age, obesity, menopause, BRCA1 or BRCA2 germline mutations, or existence of breast cancer in family history. Additionally, miRNA expression was significantly altered by prior bilateral oophorectomy, hypertension, and hypercholesterolemia. Other variables, such as smoking; parity; age at menarche; hormonal replacement therapy; oral contraception; breast, endometrial, or colon cancer; and diabetes, were not associated with significant changes in the panel when corrected for multiple testing.Conclusions:Serum miRNA expression patterns are significantly affected by patient demographics, exposure history, and medical comorbidities.Impact:Understanding confounders in serum miRNA expression is important for refining clinical assays for cancer screening.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Background:Serum miRNAs are potential biomarkers for ovarian cancer; however, many factors may influence miRNA expression. To understand potential confounders in miRNA analysis, we examined how sociodemographic factors and comorbidities, including known ovarian cancer risk factors, influence serum miRNA levels in women without ovarian cancer.Methods:Data from 1,576 women from the Mass General Brigham Biobank collected between 2012 and 2019, excluding subjects previously or subsequently diagnosed with ovarian cancer, were examined. Using a focused panel of 179 miRNA probes optimized for serum profiling, miRNA expression was measured by flow cytometry using the Abcam FirePlex assay and correlated with subjects’ electronic medical records.Results:The study population broadly reflected the New England population. The median age of subjects was 49 years, 34% were current or prior smokers, 33% were obese (body mass index > 30 kg/m2), 49% were postmenopausal, and 11% had undergone prior bilateral oophorectomy. Significant differences in miRNA expression were observed among ovarian risk factors such as age, obesity, menopause, BRCA1 or BRCA2 germline mutations, or existence of breast cancer in family history. Additionally, miRNA expression was significantly altered by prior bilateral oophorectomy, hypertension, and hypercholesterolemia. Other variables, such as smoking; parity; age at menarche; hormonal replacement therapy; oral contraception; breast, endometrial, or colon cancer; and diabetes, were not associated with significant changes in the panel when corrected for multiple testing.Conclusions:Serum miRNA expression patterns are significantly affected by patient demographics, exposure history, and medical comorbidities.Impact:Understanding confounders in serum miRNA expression is important for refining clinical assays for cancer screening.
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Raw data from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Raw data, miRNAs and clinical data
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessRaw data from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Raw data, miRNAs and clinical data
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Significant miRNA changes for age, menopause and bilateral salpingo-oophorectomy (BSO)
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Significant miRNA changes for age, menopause and bilateral salpingo-oophorectomy (BSO)
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Univariate analysis of clinical variables with miRNAs.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Univariate analysis of clinical variables with miRNAs.
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Log2 expression values of miRNAs used for statistical tests.
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Log2 expression values of miRNAs used for statistical tests.
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Patient characteristics in tSNE clusters
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
Patient characteristics in tSNE clusters
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
- Open Access
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
- 3 March 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Effects of Clinical Covariates on Serum miRNA Expression among Women without Ovarian Cancer
- Open Access
- 17 October 2024
- Published by Elsevier in Kidney Medicine
- Vol. 6 (12) , 100917
Perceptions of Palliative Care Among Patients With Kidney Allograft Dysfunction: A Qualitative Study
- 17 October 2024
- Published by Elsevier in Kidney Medicine
- Vol. 6 (12) , 100917
Open AccessPerceptions of Palliative Care Among Patients With Kidney Allograft Dysfunction: A Qualitative Study